0000105770-24-000088.txt : 20241213 0000105770-24-000088.hdr.sgml : 20241213 20241213160206 ACCESSION NUMBER: 0000105770-24-000088 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20241209 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20241213 DATE AS OF CHANGE: 20241213 FILER: COMPANY DATA: COMPANY CONFORMED NAME: WEST PHARMACEUTICAL SERVICES INC CENTRAL INDEX KEY: 0000105770 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 231210010 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-08036 FILM NUMBER: 241548278 BUSINESS ADDRESS: STREET 1: 530 HERMAN O. WEST DRIVE CITY: EXTON STATE: PA ZIP: 19341 BUSINESS PHONE: 6105942900 MAIL ADDRESS: STREET 1: 530 HERMAN O. WEST DRIVE CITY: EXTON STATE: PA ZIP: 19341 FORMER COMPANY: FORMER CONFORMED NAME: WEST CO INC DATE OF NAME CHANGE: 19990405 8-K 1 wst-20241209.htm 8-K wst-20241209
0000105770false00001057702024-12-092024-12-09

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) – December 9, 2024
wstlogoq319.jpg
WEST PHARMACEUTICAL SERVICES, INC.
(Exact name of registrant as specified in its charter)
Pennsylvania
1-8036
23-1210010
(State or other jurisdiction
of incorporation)
(Commission File Number)
(IRS Employer
Identification No.)
530 Herman O. West Drive, Exton, PA
19341-1147
(Address of principal executive offices)
(Zip Code)
 Registrant’s telephone number, including area code: 610-594-2900
Not Applicable
(Former name or address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading SymbolName of each exchange on which registered
Common Stock, par value $0.25 per shareWSTNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

1


Item 8.01 Other Events.

On December 9, 2024, the Board of Directors approved a share repurchase program authorizing the repurchase of up to 550,000 shares of our common stock from time to time on the open market or in privately-negotiated transactions as permitted under Exchange Act Rule 10b-18. The number of shares to be repurchased and the timing of such transactions will depend on a variety of factors, including market conditions. This share repurchase program is expected to be completed by December 31, 2025. The Company's previously-authorized share repurchase program is expected to expire by December 31, 2024.

Item 9.01 Financial Statements and Exhibits.
(d)
Exhibit No.
Description
 104
The cover page from the Company’s Current Report on Form 8-K, dated December 9, 2024, formatted in Inline XBRL.



2




SIGNATURE


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


WEST PHARMACEUTICAL SERVICES, INC.
/s/ Kimberly Banks MacKay
Kimberly Banks MacKay
Senior Vice President, General Counsel and Secretary
December 13, 2024



3





EXHIBIT INDEX

Exhibit No.
Description
104
The cover page from the Company’s Current Report on Form 8-K, dated December 9, 2024, formatted in Inline XBRL.

4
 EX-101.SCH 2 wst-20241209.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover Page link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 3 wst-20241209_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Central Index Key Entity Central Index Key Entity File Number Entity File Number Entity Address, State or Province Entity Address, State or Province Security Exchange Name Security Exchange Name Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Entity Address, Address Line One Entity Address, Address Line One Entity Address, City or Town Entity Address, City or Town Soliciting Material Soliciting Material Entity Address, Postal Zip Code Entity Address, Postal Zip Code Cover [Abstract] Written Communications Written Communications Local Phone Number Local Phone Number Title of 12(b) Security Title of 12(b) Security City Area Code City Area Code Document Period End Date Document Period End Date Amendment Flag Amendment Flag Entity Tax Identification Number Entity Tax Identification Number Trading Symbol Trading Symbol Entity Registrant Name Entity Registrant Name Pre-commencement Tender Offer Pre-commencement Tender Offer Document Type Document Type Entity Emerging Growth Company Entity Emerging Growth Company EX-101.PRE 4 wst-20241209_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 5 wst-20241209_g1.jpg GRAPHIC begin 644 wst-20241209_g1.jpg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end XML 7 R1.htm IDEA: XBRL DOCUMENT v3.24.3
Cover Page
Dec. 09, 2024
Cover [Abstract]  
Entity Central Index Key 0000105770
Document Type 8-K
Document Period End Date Dec. 09, 2024
Entity Registrant Name WEST PHARMACEUTICAL SERVICES, INC.
Entity Incorporation, State or Country Code PA
Entity File Number 1-8036
Entity Tax Identification Number 23-1210010
Entity Address, Address Line One 530 Herman O. West Drive
Entity Address, City or Town Exton
Entity Address, State or Province PA
Entity Address, Postal Zip Code 19341-1147
City Area Code 610
Local Phone Number 594-2900
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.25 per share
Trading Symbol WST
Security Exchange Name NYSE
Entity Emerging Growth Company false
Amendment Flag false
EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( $* C5D'04UB@0 +$ 0 9&]C4')O<',O87!P+GAM M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGDK7A.YNJQ<&4GPZ4A!0W_J=0U[R;UEA_6\#MI7E!+ P04 M " !"@(U9C(*D'>X K @ $0 &1O8U!R;W!S+V-O&ULS9+/ M2L0P$(=?17)OITG50^CFHGA2$%Q0O(5D=C?8_"$9:??M;>MN%]$'\)B97[[Y M!J8S29J8\3G'A)DJLD2:CIIA/>&M6?/K,_0*S!K!'CX$*\)H#4_/$ M=!S[#BZ &4:8??DNH%V)2_5/[-(!=DJ.Q:VI81CJH5URTPX7Y9U*Q<* MZ6!P^E6_[D)] 5!+ P04 " !"@(U9F5R<(Q & "<)P $P 'AL+W1H M96UE+W1H96UE,2YX;6SM6EMSVC@4?N^OT'AG]FT+QC:!MK03621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X M8-DOV]:[MR_>X%#BVR]*+ M41B1%G\@M MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7 MH5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76>)7 \:V< M/!T3$LV4"P9!AI@S M&L%&KQMUAVC2/'K^!?F<-0HACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0' MHYI9";V$5FJ?JH,@H%\;D>/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y M?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RSTS0LS0[=R2^JVE+ZU)CA* M]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D* MTU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-# MAWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B M?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*P MOFH]M!5.S_Y9KF4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=W MP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5' 86%S+D4.Z2 MD 83 >LX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F M$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+ M!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'5 M0.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0 ( M $* C5GM-8-#5 0 ) 0 8 >&PO=V]R:W-H965T&UL ME9AM;^HV%,>_BI5-TR;QD(2GT@$2I71%MP^HX=YJF_;") :L)G:N;0K]]CL. M-&&ZX83U18D3GS\_V\?_$S/82?6F-XP9LD]BH8?.QICTNMG4X88E5#=DR@0\ M64F54 --M6[J5#$:94%)W/1=M]M,*!?.:)#=FZO10&Y-S 6;*Z*W24+5QPV+ MY6[H>,[GC1>^WAA[HSD:I'3- F:^IG,%K6:N$O&$"&<3%L=6"3B^'T6=_#MMX.GU MI_I=-G@8S))J-I'Q*X_,9NA<.21B*[J-S8O9$/- MH@&."[LJ@5'PE$.<&4WD.U-D#@LP:!K0LW>;X3'VYA#KGXF]96&#N/T:\5V_ M_=_P)F#D+'[.XF=Z+93E[_%2&P6K]4\9T4&A7:Y@4_A:IS1D0P=R5#/USIS1 M+S]Y7?=WA*^5\[4P]=%4&&X^R(0)X(O)3$1L3[ZPCS).7,F%/\_M]'HN@M7. ML=JHV*T,M[!/#%E\I*6KB(=?U;\@$)T=7.V[B7K]L+6W&860#[1I)0,UWF=!@LROQ^_/(XGTZ^+V63\0(+IR[?9 M9!K4R.QITD!@>SEL[Q+8F0BE2J6BUKMJ)# PET0J,I%;R#Y(0AF5C@ 7GX\1 MPJN<\.H2PCL>,_*T399,E8'@&E[]RFUU$9A^#M._!&9!]V060?[Q%0^S.4/0 M<$6_5?=\S^Y/!,]S"W]U+P$<1Q$8DJY]7I 'Z$>>1;GMXI*=EDON&90D09X; MY)5I0VX5U#:,]Z0>>/^+=V);D'@+N1.EK!5R>R,%!E84!P_U]A_ \BTQ5_*= MB[!\)G%-=#]X15WP+BH,.=I<:@,%XB^>GMVG%8I>O]7VZI[7[F& 187P<(_/ M%G$,;VWG>7"!+KX;BBKAX>;^($.8F/E&"LP[*D0Z_7;=[[LH45$;O I35]P8 M)F!BDF0KCN:A2ZEPH16--;H%BPK@X2X=R)B'W'"Q)H^0XXK3N)0'5ZGD*?S> MP\UZKE@]A.EAL,D.+QH,7GT4>5ZMSJP?KE=)5IB_AWOU#V0SK;= 5@F(RU8! M^H7[^[A5+[B!*BE7Q/-_7?Y& A9N(=]*WQ@KE&Q^0E4+C S?:B2EBKS3>,O( MSV[#[Y 41JLW5*'410WP<=->*!K9[ L^DJ4LS;T*@==@@8&<' AP?_Z<+S+= MAQLJUNSLFUN%T-.?P10C*JS>O\CJIPE3:SM%?X""V5CW2*DH7U=PPZ(LEUP%]-U*0HN7*^M&?U1VH'KTG,5B#D-GK@U^IP_#TTC$RS M(^=2&CC 9I<;1F%+V@[P?"6E^6S84VS^(\3H7U!+ P04 " !"@(U9GZ ; M\+$" #B# #0 'AL+W-T>6QEO%DN7/ZZZ>S;"=I=67=A['-HN6/O.-%Q[I#)6,>=56R=M8SDK6W!2,EG>W&2) M8D+38JT[=:=<2PZFTVY#;VA2K"NCSY:4!H-?RA0GCTQNZ)9)L;=B6,N4D*=@ M7H+A8*2QQ'DJ?$,78&F? KP(&K XU7=>&18/QA<0&>7=J?$,:\M.B^4M/3L,/S[)WMB2VSG-@DZF8BUY M!72LJ(_PZTR3 .B<45XH!:N-9@.'R6,4?-@#E_(!6OBMNHK=5R3TXE,);2"P MU4GTA$8QA D*Q+^,%F)?A+W]K;"D$8_&?>S\;O2@?^^,X_>65Z(?]+Z:\V/1 M%WATUC3R]$&*6BL>]O[+"8LUF_S(T5CQY+/!I!R\@5M*'KEUXG!I^6%9L^.] MFZ:IKW#.RW^0\Y^M<\TUMTQ>DO:C_S=7^2V,D_'T7!S1JP,Z6PEY7 M>>9 ]IV03NA1.XJRY/K%.?7A'=O["_PJOE]?\HIUTNUF<$//\A=>BD[E\ZI[ MJ,NXZBQ_AOMHD\%G'!QR>(W?#$T%^@2O&+(=/EB>N$_NG_A.\SQ-LPRK MZ'8;9;#%ZI9E\!>/AG$##RP/9'I;K?%NXQ/R^AQ@/7UM0K"=XI.([12O-2#Q MNH%'GL>[C>4!#ZP+V.Q _G@>F*FX3YI"5S%NV G&D3S'$)C%^(QF&5*=##[Q M_F"G)$WS/(X %F>0IA@"IQ%', ; 4/2='@//GL?)=-[*CG_5U/\!%!+ P04 M " !"@(U9EXJ[', 3 @ "P %]R96QS+RYR96QSG9*Y;L,P#$!_ MQ=">, ?0(8@S9?$6!/D!5J(/V!(%BD6=OZ_:I7&0"QEY/3P2W!YI0.TXI+:+ MJ1C]$%)I6M6X 4BV)8]ISI%"KM0L'C6'TD!$VV-#L%HL/D N&6:WO606IW.D M5XA-/E_G;@ M2=&A(E@6FD7)TZ(=I7\=Q_:0T^FO8R*T>EOH^7%H5 J.W&,EC'%BM/XU@LD/ M['X 4$L#!!0 ( $* C5D9117U-P$ "<" / >&PO=V]R:V)O;VLN M>&ULC5'1;L(P#/R5*A^P%K0A#5%>0-N0I@V-B??0NM0BB2O'A8VOG]NJ&M)> M]I31=B;FJ19IZFL:C!VWA'#02=5,3>BD(^IK%AL&6L M <2[=)IEL]1;#&:Y&+6VG-X"$B@$*2C9$7N$2_R==S Y8\0#.I3OW/1W!R;Q M&-#C%B/%*0:S;%4S.Y68R#/; @L4?>M>9_+2'V#-B#Q]6C>1F MEJE@A1REW^CUK7H\@RX/J!5Z0B? :ROPS-0V&(Z=C*9(;V+T/8SG4.*<_U,C M5146L*:B]1!DZ)'!=09#K+&))@G60VY6= 9.MO8(72A]95,. 46=W=3%<]0! M;\K!XVBLA H#E&^J%977DHHM)]W1ZTSO'R:/6D;KW$JY]_!*MAQSCG^T_ %0 M2P,$% @ 0H"-620>FZ*M ^ $ !H !X;"]?+7_OR4Z?:!1W;J"V\R1&:P;*9,OL[P"D6[2*+L[C,$]J%ZSB688& MO-*]:A"2*+I!V#-DGNZ9HIP\_D-T==UI?#C]LCCP#S"\7>BI160I2A4:Y$S" M:+8VP5+BRTR6HJ@R&8HJEG!:(.+)(&UI5GVP3TZTYWD7-_=%KLWC":[?#'!X M=/X!4$L#!!0 ( $* C5EED'F2&0$ ,\# 3 6T-O;G1E;G1?5'EP M97-=+GAM;*V334[#,!"%KQ)E6R4N+%B@IAM@"UUP 6-/&JO^DV=:TMLS3MI* MH!(5A4VL>-Z\SYZ7K-Z/$;#HG?78E!U1?!0"50=.8ATB>*ZT(3E)_)JV(DJU MDUL0]\OE@U#!$WBJ*'N4Z]4SM')OJ7CI>1M-\$V9P&)9/(W"S&I*&:,U2A+7 MQ<'K'Y3J1*BY<]!@9R(N6%"*JX1<^1UPZGL[0$I&0[&1B5ZE8Y7HK4 Z6L!Z MVN+*&4/;&@4ZJ+WCEAIC JFQ R!GZ]%T,4TFGC",S[O9_,%F"LC*30H1.;$$ M?\>=(\G=560C2&2FKW@ALO7L^T%.6X.^DX K @ $0 @ &O 9&]C4')O<',O M8V]R92YX;6Q02P$"% ,4 " !"@(U9F5R<(Q & "<)P $P M @ ', 0 >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0 ( $* C5GM M-8-#5 0 ) 0 8 " @0T( !X;"]W;W)K&PO&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4 " !" M@(U999!YDAD! #/ P $P @ &E$@ 6T-O;G1E;G1?5'EP =97-=+GAM;%!+!08 "0 ) #X" #O$P ! end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.3 html 1 22 1 false 0 0 false 0 false false R1.htm 0000001 - Document - Cover Page Sheet http://www.westpharma.com/role/CoverPage Cover Page Cover 1 false false All Reports Book All Reports wst-20241209.htm wst-20241209.xsd wst-20241209_lab.xml wst-20241209_pre.xml wst-20241209_g1.jpg http://xbrl.sec.gov/dei/2024 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "wst-20241209.htm": { "nsprefix": "wst", "nsuri": "http://www.westpharma.com/20241209", "dts": { "inline": { "local": [ "wst-20241209.htm" ] }, "schema": { "local": [ "wst-20241209.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.sec.gov/dei/2024/dei-2024.xsd" ] }, "labelLink": { "local": [ "wst-20241209_lab.xml" ] }, "presentationLink": { "local": [ "wst-20241209_pre.xml" ] } }, "keyStandard": 22, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2024": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 23, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2024": 22 }, "report": { "R1": { "role": "http://www.westpharma.com/role/CoverPage", "longName": "0000001 - Document - Cover Page", "shortName": "Cover Page", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "wst-20241209.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "wst-20241209.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentFlag", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CityAreaCode", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentType", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFileNumber", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityRegistrantName", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "LocalPhoneNumber", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement Issuer Tender Offer", "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementTenderOffer", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement Tender Offer", "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Security12bTitle", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Title of 12(b) Security", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SecurityExchangeName", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Security Exchange Name", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SolicitingMaterial", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Soliciting Material", "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "TradingSymbol", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "WrittenCommunications", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Written Communications", "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14a", "Subsection": "12" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 15 0000105770-24-000088-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000105770-24-000088-xbrl.zip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wst-20241209_htm.xml IDEA: XBRL DOCUMENT 0000105770 2024-12-09 2024-12-09 0000105770 false 8-K 2024-12-09 WEST PHARMACEUTICAL SERVICES, INC. PA 1-8036 23-1210010 530 Herman O. West Drive Exton PA 19341-1147 610 594-2900 false false false false Common Stock, par value $0.25 per share WST NYSE false